Haemonetics Corporation
HAE
Xếp hạng trong cổ phiếu
#3288
Haemonetics Corporation is a healthcare enterprise dedicated to providing... Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
Giá cổ phiếu
$118.24
Vốn hóa thị trường
$5.38B
Thay đổi (1 ngày)
-0.22%
Thay đổi (1 năm)
133.16%
Quốc gia
US
Giao dịch Haemonetics Corporation (HAE)
Danh mục
Healthcare
Tỷ lệ P/B của Haemonetics Corporation (HAE)
Tỷ lệ P/B vào October 2026 TTM: 6.56
Theo các báo cáo tài chính và giá cổ phiếu mới nhất của Haemonetics Corporation, tỷ lệ P/B hiện tại (TTM) là 6.56. Vào cuối năm 2024, công ty có P/B là 4.48.
Lịch sử tỷ lệ P/B của Haemonetics Corporation từ 2000 đến 2026
Tỷ lệ P/B vào cuối mỗi năm
| Năm | Tỷ lệ P/B | Thay đổi |
|---|---|---|
| 2026 (TTM) | 6.56 | 69.58% |
| 2025 | 3.87 | -13.49% |
| 2024 | 4.48 | -12.82% |
| 2023 | 5.14 | 18.12% |
| 2022 | 4.35 | -43.97% |
| 2021 | 7.76 | -10.95% |
| 2020 | 8.72 | 29.13% |
| 2019 | 6.75 | 31.59% |
| 2018 | 5.13 | 81.56% |
| 2017 | 2.83 | 13.22% |
| 2016 | 2.50 | -9.51% |
| 2015 | 2.76 | 39.72% |
| 2014 | 1.97 | -29.03% |
| 2013 | 2.78 | 15.67% |
| 2012 | 2.40 | -1.18% |
| 2011 | 2.43 | 0.39% |
| 2010 | 2.42 | -5.89% |
| 2009 | 2.58 | -16.05% |
| 2008 | 3.07 | 17.66% |
| 2007 | 2.61 | -14.35% |
| 2006 | 3.04 | 2.25% |
| 2005 | 2.98 | 8.64% |
| 2004 | 2.74 | 10.80% |
| 2003 | 2.47 | -29.61% |
| 2002 | 3.51 | -9.58% |
| 2001 | 3.89 | 36.66% |
| 2000 | 2.84 | 0.00% |
Tỷ lệ P/B của các công ty tương tự hoặc đối thủ cạnh tranh
| Công ty | Tỷ lệ P/B | Chênh lệch Tỷ lệ P/B | Quốc gia |
|---|---|---|---|
| 3.5116 | -46.49% |
US
|
|
| 2.0146 | -69.30% |
IE
|
|
| 4.5025 | -31.39% |
US
|
|
| 2.5486 | -61.17% |
US
|
|
| - | - |
DE
|
